BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Holistic medicine, Doxorubicin, rs2230926, PTEN, Angiogenesis, Breast Cancer, Stem cell)
Bookmark Forward

QuickView for CDH3 (gene)


Body Atlas

Most Correlated Tissues

  1. Ovary
  2. Penis
  3. Vulva
  4. Breast tissue
  5. Conjunctiva
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hypotrichosis
  2. Ulceration of intestine
  3. Bronchitis
  4. Interstitial lung disease
  5. Malignant tumor of intestine
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. pertuzumab
  2. transplatin
  3. R788 compound
  4. 4-chloroaniline
  5. N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. OPRPN
  2. STAG1
  3. SPRY2
  4. PPIB
  5. SQSTM1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The transcription factors Junb and Fosl2 cooperate to regulate Cdh3 expression in 15P-1 Sertoli cell…
  2. Functional evaluation of mineral trioxide aggregate cement with choline dihydrogen phosphate.
  3. Downregulated CDH3 is correlated with a better prognosis for LUAD and decreases proliferation and mi…
  4. CDH3 Is an Effective Serum Biomarker of Colorectal Cancer Distant Metastasis Patients.
  5. Alteration of Cadherin 3 Expression and DNA Methylation in Association with Aggressive Renal Cell Ca…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer
  2. A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Squamous Non-Sm…
  3. A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer
  4. STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.